CXCL12 and diabetes mellitus: The protein expression of both VEGF and SDF-1 in the ischemic gastrocnemius muscle was increased by 100 μg CXCL5 neutralizing antibody after 4 weeks treatment compared to the DM and DM with IgG antibody treatment groups (Fig. 5E).